Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.
AffiliationDepartment of Endocrinology and Diabetes, Adelaide and Meath Hospital, and School, of Public Health and Population Science, University College Dublin, Dublin 24,, Ireland.
Body Mass Index
Electrophoresis, Polyacrylamide Gel
Glucose Tolerance Test
Polycystic Ovary Syndrome/*blood
MetadataShow full item record
CitationJ Clin Endocrinol Metab. 2010 Aug;95(8):3933-9. Epub 2010 Jun 2.
JournalThe Journal of clinical endocrinology and metabolism
AbstractOBJECTIVES: Women with polycystic ovary syndrome (PCOS) are more insulin resistant and display an atherogenic lipid profile compared with normal women of similar body mass index (BMI). Insulin resistance (IR) at least partially underlies the dyslipidemia of PCOS, but it is unclear whether PCOS status per se confers additional risk. RESEARCH DESIGN AND METHODS: Using a case-control design, we compared plasma lipids and lipoprotein subclasses (using polyacrylamide gel tube electrophoresis) in 70 women with PCOS (National Institutes of Health criteria) and 70 normal women pair matched for age, BMI, and IR (homeostasis model assessment-IR, quantitative insulin sensitivity check index, and the Avignon Index). Subjects were identified as having a (less atherogenic) type A pattern consisting predominantly of large low-density lipoprotein (LDL) subfractions or a (more atherogenic) non-A pattern consisting predominantly of small-dense LDL subfractions. RESULTS: Total, high-density lipoprotein, or LDL cholesterol, or triacylglycerol did not differ between the groups, but very low-density lipoprotein levels (P<0.05) were greater in women with PCOS, whereas a non-A LDL profile was seen in 12.9% compared with 2.9% of controls (P<0.05, chi2). Multiple regression analysis revealed homeostasis model assessment-IR and waist circumference to be independent predictors of very low-density lipoprotein together explaining 40.2% of the overall variance. Logistic regression revealed PCOS status to be the only independent determinant of a non-A LDL pattern (odds ratio 5.48 (95% confidence interval 1.082-27.77; P<0.05). CONCLUSIONS: Compared with women matched for BMI and IR, women with PCOS have potentially important differences in lipid profile with greater very low-density lipoprotein levels and increased rates of a more atherogenic non-A LDL pattern.
- Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
- Authors: Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH, Kim SM, Ku SY, Kim SH, Kim JG, Moon SY
- Issue date: 2013 May
- [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
- Authors: Wan DH, Fan P, Bai H, Song Q, Liu HW
- Issue date: 2010 Jan
- Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
- Authors: Yang S, Li Q, Zhong L, Song Y, Tian B, Cheng Q, Qing H, Xia W, Luo M, Mei M
- Issue date: 2011 Mar
- Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
- Authors: Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F
- Issue date: 2012 Aug
- Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
- Authors: Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N
- Issue date: 2001 Apr